HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
|
Citation:
|
HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
|
HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
|
Citation:
|
HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
|
DownLoad: